Argentina 
Asia-pacific 
Austria 
Brazil 
England 
Germany 
Hong Kong 
Malaysia 
Netherlands 
Poland 
Switzerland 
France 
Join us at the International Symposium on Intra Articular Treatment in Athens (past event)
We are excited to announce that we will be attending the ISIAT Congress 2023, the international symposium for ultrasound-guided intra-articular treatment, and we are looking forward to sharing our latest research with the global community.
The congress will be held in Athens, Greece from October 5-7, 2023. This will be the opportunity to present the preliminary results of our latest study evaluating the effectiveness of hyaluronic acid and mannitol to relieve symptoms in hip osteoarthritis. We will also be attending the scientific sessions and networking with other experts in the field.
We invite you to explore our Rheumatology webpage, where you can delve into our dedication to advancing hyaluronic acid-based treatments for rheumatology and tendinopathy. Discover how we’re reshaping these fields with innovative approaches.
We look forward to meeting you in Athens and on our webpage!
We are proudly sponsoring the 2023 OARSI Conference in Denver to advance osteoarthritis treatment and prevention (past event)
At TRB Chemedica, we are committed to advancing the field of osteoarthritis treatment by researching, developing, manufacturing, and marketing various molecules, such as hyaluronic acid and diacerein, to manage osteoarthritis-induced pain.
As osteoarthritis is one of our areas of focus, we are pleased to announce our sponsorship of this year’s Osteoarthritis Research Society International (OARSI) conference in Denver, which is dedicated to advancing prevention and treatment of osteoarthritis, and thus support their mission.
We are pleased to participate in World Arthritis Day (past event)
World Arthritis Day, referred to as WAD, aims at increasing disease awareness and knowledge on rheumatological conditions around the world. Current estimates list more than 200 rheumatic and musculoskeletal diseases (RMD), but their burden is largely underestimated by the general population. Consequently, a large proportion of patients are either not diagnosed or wait for extended periods of time before consulting their healthcare professionals.
More than 100.000.000 people worldwide suffer from rheumatological symptoms. These symptoms directly impact the quality of life of the patients and their professional activity. The inability to work reduces individuals’ self-esteem and increases their dependence on social assistance, family and friends.
Medical education has for a long time considered RMDs as second priority conditions, which means that symptoms might go unnoticed, misdiagnosed, or mistreated if people don’t have access to rheumatologists, nurses, physical therapists, or other healthcare professionals specifically trained in the field of RMD. As a result, people living with a rheumatic or musculoskeletal disease often have to face their condition alone and are lacking information on their symptoms, diagnosis and treatment options.
World Arthritis Day is intended to raise awareness on the existence and impact of RMD worldwide. This Day is an opportunity for all communities around the world to come together and speak with one voice to bring the much-needed messages to all audiences.
Over the past 20 years, TRB Chemedica has focused its rheumatological activities on osteoarthritis, the most prevalent joint disorder especially in middle-aged and elderly people.
Celebrating 20 years of healthcare excellence in the United Kingdom!
We are proud to announce the 20th anniversary of TRB UK! Responsible for marketing our rheumatology and ophthalmology product ranges in the UK and Ireland since 2002, TRB UK is an ISO 9001 certified company, an achievement that demonstrates our commitment to patients and healthcare professionals and our dedication to quality.
Join us at the European Society of Cataract and Refractive Surgeons Congress (past event)
Visit us at the 40th ESCRS Congress in Milan. We look forward to welcoming you at our booth B40 from September 16 to 20, 2022.
